LEVETIRACETAM
Generic: LEVETIRACETAM
LEVETIRACETAM is FDA application NDA207958, sponsored by APRECIA PHARMS. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Lack of Assurance of Sterility; confirmed customer report of a leaking bags and mold found between t
Lack of Assurance of Sterility; confirmed customer report of a leaking bags and mold found between t
LABELING: LABEL MIX-UP: The infusion bag is incorrectly labeled as Levetiracetam in 0.82% Sodium Chl
Presence of foreign substance (screw)
CGMP Deviations: Products were manufactured in a processing area in which water leakage was observed
Labeling: Label Error on Declared Strength; the pre-printed text on the primary infusion bag and the
Lack of Assurance of Sterility; confirmed customer report of a leaking bags and mold found between t
Adulterated Presence of Foreign Tablets: Pharmaceutical manufacturer may have distributed foreign ta